Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB26FJACU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,091
Award facts
- Contract value 100% obligated
- $16,091.01 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $16,091.01 delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen injections on October 14, 2025, with completion scheduled for October 15, 2025. This is a firm fixed price, non-set-aside contract performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, supplies critical pharmaceutical products and medical commodities to support military and federal healthcare systems through the DLA Medical Supply Chain. The SPE2DX IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to fulfill diverse medical procurement needs across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical supplies for military healthcare programs worldwide. This delivery order for Dupixent, a biologic immunosuppressant used to treat conditions such as atopic dermatitis and asthma, reflects the company's continued role as a prime vendor supporting Defense Health Agency and other federal healthcare customers.
Quick answers
Who was awarded contract SPE2DB26FJACU?
SPE2DB26FJACU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 14, 2025.
How much is contract SPE2DB26FJACU worth?
The government has obligated $16,091 on SPE2DB26FJACU.
Is contract SPE2DB26FJACU an order under another contract?
Yes. SPE2DB26FJACU is a delivery order under SPE2DB24D1201, an indefinite delivery contract.
Was contract SPE2DB26FJACU competed?
The extent of competition for SPE2DB26FJACU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award